NorthView Acquisition (NVACW) Competitors $0.14 0.00 (0.00%) As of 09/12/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock NVACW vs. DRTSW, ANZUW, ATAKW, BBLGW, HSCSW, BEATW, LUCYW, IINNW, NXGLW, and NTRBWShould you be buying NorthView Acquisition stock or one of its competitors? The main competitors of NorthView Acquisition include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), Innovative Eyewear (LUCYW), Inspira Technologies Oxy B.H.N. (IINNW), NEXGEL (NXGLW), and Nutriband (NTRBW). These companies are all part of the "medical equipment" industry. NorthView Acquisition vs. Its Competitors Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Heart Test Laboratories HeartBeam Innovative Eyewear Inspira Technologies Oxy B.H.N. NEXGEL Nutriband NorthView Acquisition (NASDAQ:NVACW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations. Does the media favor NVACW or DRTSW? In the previous week, Alpha Tau Medical had 1 more articles in the media than NorthView Acquisition. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for NorthView Acquisition. Alpha Tau Medical's average media sentiment score of 1.91 beat NorthView Acquisition's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media. Company Overall Sentiment NorthView Acquisition Neutral Alpha Tau Medical Very Positive Which has higher earnings & valuation, NVACW or DRTSW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNorthView AcquisitionN/AN/AN/AN/AN/AAlpha Tau MedicalN/AN/AN/AN/AN/A Is NVACW or DRTSW more profitable? Company Net Margins Return on Equity Return on Assets NorthView AcquisitionN/A N/A N/A Alpha Tau Medical N/A N/A N/A SummaryAlpha Tau Medical beats NorthView Acquisition on 2 of the 2 factors compared between the two stocks. Get NorthView Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for NVACW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVACW vs. The Competition Export to ExcelMetricNorthView AcquisitionShell Companies IndustryFinancial SectorNASDAQ ExchangeMarket CapN/A$32.52M$6.37B$10.27BDividend YieldN/A5.35%4.31%4.60%P/E RatioN/A8.221,780.7526.24Price / SalesN/A401.901,356.9790.99Price / CashN/A178.7348.9929.91Price / BookN/A3.242.076.30Net IncomeN/A-$141.08M$1.23B$270.76M7 Day PerformanceN/A0.41%6.83%3.03%1 Month PerformanceN/A1.83%7.55%6.38%1 Year PerformanceN/A76.78%32.10%26.35% NorthView Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVACWNorthView AcquisitionN/A$0.14flatN/AN/A$0.00N/A0.002DRTSWAlpha Tau MedicalN/A$0.28-10.1%N/AN/A$0.00N/A0.0080Positive NewsANZUWAnzu Special Acquisition Corp IN/A$0.03-34.0%N/A-29.9%$0.00N/A0.002Gap UpATAKWAurora Technology AcquisitionN/A$0.02flatN/A-67.0%$0.00N/A0.00N/AGap UpBBLGWBone BiologicsN/A$10.79-28.1%N/AN/A$0.00N/A0.002Gap DownHSCSWHeart Test LaboratoriesN/A$0.06-22.9%N/AN/A$0.00$4.35K0.0010Gap DownBEATWHeartBeamN/A$0.35-0.2%N/A-57.6%$0.00N/A0.005Gap DownLUCYWInnovative EyewearN/A$0.07-16.9%N/A+143.1%$0.00$1.98M0.009Gap UpIINNWInspira Technologies Oxy B.H.N.N/A$0.32-8.4%N/A+20.7%$0.00N/A0.0020Gap DownNXGLWNEXGELN/A$0.29-3.3%N/AN/A$0.00$11.67M0.0010Gap DownNTRBWNutribandN/A$1.59-0.5%N/A+42.5%$0.00$2.40M0.0010Gap Down Related Companies and Tools Related Companies DRTSW Alternatives ANZUW Alternatives ATAKW Alternatives BBLGW Alternatives HSCSW Alternatives BEATW Alternatives LUCYW Alternatives IINNW Alternatives NXGLW Alternatives NTRBW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NVACW) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NorthView Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share NorthView Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.